![Glen Clack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 10 007 $ al 31/10/2026
Glen Clack is currently Chief Medical Officer at TheraCryf Plc since 2021.
Dr. Clack holds a doctorate from The University of Sheffield and an undergraduate degree from Royal Free Hospital School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
THERACRYF PLC 0,16 % | 09/09/2026 | 4.388.888 ( 0,16 % ) | 10 007 $ | 31/10/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| THERACRYF PLC | Director Técnico/Científico/I+D | 01/05/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Free Hospital School of Medicine
 Royal Free Hospital School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
